These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8852502)

  • 1. Decreased cyclosporine levels during gemfibrozil treatment of hyperlipidemia after kidney transplantation.
    Fehrman-Ekholm I; Jogestrand T; Angelin B
    Nephron; 1996; 72(3):483. PubMed ID: 8852502
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of effect of gemfibrozil on cyclosporine blood concentrations in kidney-transplanted patients.
    Pisanti N; Stanziale P; Imperatore P; D'Alessandro R; De Marino V; Capone D; De Marino V
    Am J Nephrol; 1998; 18(3):199-203. PubMed ID: 9627035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin and pravastatin on hyperlipidemia and cyclosporin blood levels in renal transplant recipients.
    Capone D; Stanziale P; Gentile A; Imperatore P; Pellegrino T; Basile V
    Am J Nephrol; 1999; 19(3):411-5. PubMed ID: 10393380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment.
    Kolovou GD; Cokkinos DV
    Curr Med Res Opin; 2002; 18(5):265-8. PubMed ID: 12240788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gemfibrozil on peripheral atherosclerosis and platelet activation in a pig model of hyperlipidemia.
    Royo T; Alfón J; Berrozpe M; Badimon L
    Eur J Clin Invest; 2000 Oct; 30(10):843-52. PubMed ID: 11029597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men.
    Dumont M; Mauriège P; Bergeron J; Després JP; Prud'homme D
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1136-43. PubMed ID: 11477498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated blood concentrations of cyclosporine and kidney failure after bezafibrate in renal graft recipient.
    Hirai M; Tatuso E; Sakurai M; Ichikawa M; Matsuya F; Saito Y
    Ann Pharmacother; 1996; 30(7-8):883-4. PubMed ID: 8826580
    [No Abstract]   [Full Text] [Related]  

  • 9. Gemfibrozil, stretching arms beyond lipid lowering.
    Roy A; Pahan K
    Immunopharmacol Immunotoxicol; 2009; 31(3):339-51. PubMed ID: 19694602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hyperlipidemia with gemfibrozil.
    Hartshorn JC; Deans K
    J Cardiovasc Nurs; 1987 Aug; 1(4):76-80. PubMed ID: 3474354
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment.
    Zehngawa W
    Eur J Clin Pharmacol; 2005 Jun; 61(4):317. PubMed ID: 15891875
    [No Abstract]   [Full Text] [Related]  

  • 12. The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
    Chang DM; Fuh MM; Jeng CY; Shian LR
    Taiwan Yi Xue Hui Za Zhi; 1986 May; 85(5):443-50. PubMed ID: 3463653
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM; Cheng IK; Tam SC
    Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia.
    Ho LT; Li SH; Chou TY; Liu YF; Perng JC; Han HK; Chen JJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Jan; 39(1):1-8. PubMed ID: 3484238
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of diet and gemfibrozil on posttransplant hyperlipidemia in renal transplant recipients.
    Sapan M; Ozben B; Yakupoglu G; Suleymanlar G; Ozben T
    J Investig Med; 2009 Feb; 57(2):456-9. PubMed ID: 19174703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study.
    Jen SL; Chen JW; Lee WL; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
    Jian J; Hao X; Deng C; Zhou H; Lin J
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gemfibrozil in the treatment of lipid metabolism disorders].
    Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
    Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
    Arya N; Munde MK; Dwivedi J; Jagdale AY; Jain KS
    Arch Pharm (Weinheim); 2013 Aug; 346(8):588-95. PubMed ID: 23881664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidemia and glucose intolerance in the post-renal transplant patient.
    Markell MS; Armenti V; Danovitch G; Sumrani N
    J Am Soc Nephrol; 1994 Feb; 4(8 Suppl):S37-47. PubMed ID: 8193294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.